Leaders Engaged on Alzheimer’s Disease
All Home Care Matters was privileged to welcome Mr. Ian Kremer, J.D. as guest to the show. Ian is the Executive Director of the LEAD Coalition (Leaders Engaged on Alzheimer’s Disease).
Ian N. Kremer, JD, has worked on federal, state and local dementia policy since 1996. Since 2012, Kremer has served as Executive Director of the LEAD Coalition (Leaders Engaged on Alzheimer’s Disease: http://www.leadcoalition.org), the uniting voice of over 200 member and allied organizations.
The LEAD Coalition accelerates transformational progress in care and support to enrich the quality of life of those with dementia and their caregivers, detection and diagnosis, and research leading to prevention, effective treatment, and cures. The LEAD Coalition has helped to secure historic funding increases for the National Institutes of Health (NIH), expand Medicare services for people with dementia and protect dementia-relevant components of Medicaid and the Patient Protection and Affordable Care Act, expand the role of people with dementia and their care partners in medical product development, build a nation-wide network of dementia-friendly communities, and worked with a dozen federal agencies to overcome health disparities, clarify regulatory pathways, combat elder abuse, and improve cognitive impairment detection and diagnosis, clinical care, and access to home and community-based services.
Currently, Kremer serves on the Centers for Medicare and Medicaid Services (CMS) Medicare Evidence Development & Coverage Advisory Committee (MEDCAC), the Public Policy & Aging Report editorial board, and on steering and advisory committees for the National Institute on Aging (NIA) IMbedded Pragmatic AD/ADRD Clinical Trials (IMPACT) Collaboratory, the CDC-funded NYU School of Medicine BOLD Public Health Center of Excellence on Early Detection of Dementia and University of Minnesota Public Health Center of Excellence on Dementia Caregiving, the CDC National Healthy Brain Initiative Tribal Project (American Indian and Alaska Native Resource Center for Brain Health), the NIA-funded Hopkins’ Economics of Alzheimer’s Disease and Services (HEADS) Center and the WeCareAdvisor Study, the UCLA Dementia Care Study, the Alzheimer’s Disease Patient and Caregiver Engagement (AD PACE) initiative, the Dementia Friendly America initiative, and the Davos Alzheimer’s Collaborative Champions Cabinet.
Previously, Kremer served on the steering committees for the NIH’s 2017 and 2020 National Research Summit on Care, Services, and Supports for Persons with Dementia and Their Caregivers, the CDC Healthy Brain Initiative’s (HBI) Leadership Committee developing the 20-18-2023 and the 2023-2027 Public Health Roadmaps, and the Food & Drug Administration (FDA) Prescription Drug User Fee Act Stakeholders Working Groups for PDUFA VI and PDUFA VII. Kremer was an external reviewer for the 2021 National Academies of Science, Engineering, and Medicine report, “Meeting the Challenge of Caring for Persons Living with Dementia and Their Care Partners and Caregivers: A Way Forward.”
Kremer also has served on steering and advisory committees for a wide variety of organizations and projects including the International Collaboration for Real-World Evidence in Alzheimer’s Disease in the US (ICARE-AD-US) Study, the Gerontological Society of America Workgroup on Cognitive Impairment Detection and Earlier Diagnosis, the PCORI Dementia Research Methods project, the Brain Health Partnership, the Alzheimer’s Disease Partnership for Evidence and Value (AD EVAL), and Dementia Alliance International. Kremer holds degrees from Washington University in Saint Louis and the University of Michigan School of Law.